REFERENCES
- Noseworthy JH, Lucchinetti C, Rodriguez M, et al. Multiple sclerosis. N Engl J Med 2000; 343: 938–952
- Minagar A, Jy W, Jimenez JJ, et al. Multiple sclerosis as a vascular disease. Neurol Res 2006; 3: 230–235
- Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Ros 2006; 3: 236–244
- Delgado S, Sheremata WA. The role of CD4+ T cells in the development of MS. Neurol Res 2006; 3: 245–249
- Suidan G, Johnson AJ, Pirko I. A potential role for CD8+ T-cel Is as regu-lators of CN S vascular permeability. Neurol Res 2006; 3: 250–255
- McDole J, Johnson AJ, Pirko I. The role of CD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol Res 2006; 3: 256–261
- Zivadinov R, Nasuelli D, Tommasi MA, et al. Positivity of cyto-megalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients Neurol Res 2006; 3: 262-269
- Fritz DA, Dwyer MG, Bagnato F, et al. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. Neurol Res 2006; 3: 275–279
- Gonzalez-Toledo E, Kelley RE, Minagar A. Role of magnetic resonance spectroscopy in diagnosis and management of multiple sclerosis. Neurol Res 2006; 3: 280–283
- Pinkston JB, Alekseeva N. Neuropsychiatric manifestations of multiple sclerosis. Neurol Res 2006; 3: 284–290
- Janke AD, Yong VVV. Impact of IVIg on the interaction between activated T cells and microglia. Neurol Res 2006; 3: 270–274
- Gill V, Doig C, Knight D, et al. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation 2005; 112: 2031–2039
- Berger JR, Houff S. Progressive multifocal leukoencephalopathy: Lessons from AIDS and natalizumab. Neur Res 2006; 3: 299–305
- Bennett JL. Natalizumab and progressive multifocal leukoence-phalopathy: Migrating towards safe adhesion molecule therapy in multiple sclerosis. Neurol Res 2006; 3: 291–298
- Schwendimann RN. Treatment of symptoms in multiple sclerosis. Neurol Res 2006; 3: 306–315
- Koch M, De Keyser J. Uric acid in multiple sclerosis. Neurol Res 2006; 3: 316–319
- Patwardhan RV, Minagar A, Kelley RE, et al. Neurosurgical treatment of multiple sclerosis. Neurol Res 2006; 3: 320–325
- Rezania K, Arnason BG, Soliven B. Patterns and significance of concomitant central and peripheral inflammatory demyelination. Neurol Res 2006; 3: 326–333
- Kelley RE. Ischemic demyelination. Neurol Res 2006; 3: 334–340
- Wingerchuk DM. The clinical course of acute disseminated encephalomyelitis. Neurol Res 2006; 3: 341–347
- Wingerchuk DM. Evidence for humoral autoimmunity in neuro-myelitis optica. Neurol Res 2006; 3: 348–353
- Okai AF, Muppidi S, Bagla R, et al. Progressive necrotizing myelopathy: Part of the spectrum of neuromyelitis optica? Neurol Res 2006; 3: 354–359
- Kumar S, Fowler M, Gonzalez-Toledo E, et al. Central pontine myelinolysis: An update. Neurol Res 2006; 3: 360–366